To include your compound in the COVID-19 Resource Center, submit it here.
ALBM (Bethesda, Md.) published data from a non-blinded trial in 40 HIV-infected patients. Patients received either AZT alone; AZT
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury